Skip to main content

Vibegron Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 18, 2021.

Applies to vibegron: oral tablet.

Genitourinary

Common (1% to 10%): Urinary tract infection (6.6%), urinary retention (<2%), residual urine volume increased (<2%)[Ref]

Hematologic

Common (1% to 10%): Hot flash (<2%)[Ref]

Respiratory

Common (1% to 10%): Upper respiratory tract infection (2 %), nasopharyngitis (2.8%)[Ref]

Nervous system

Common (1% to 10%): Headache (4%)[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea (2.2%), constipation (<2%), nausea (2.2%), dry mouth (<2%)[Ref]

Dermatologic

Postmarketing reports: Pruritus, rash, drug eruption, eczema[Ref]

Frequently asked questions

References

1. "Product Information. Gemtesa (vibegron)." Urovant Sciences, Inc (2021):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.